Also known as Ziihera, the antibody treatment targets a protein called HER2, which stimulates tumour growth. It works by ...

Ben Sasse (R–Neb.), who previously served as president of the University of Florida, revealed in late December that he had ...

A 64-year-old with advanced prostate cancer underwent robotic surgery after hormonal therapy, achieving successful tumour ...

NHS approves new treatment for aggressive cancer that could triple life expectancy - Also known as Ziihera, the antibody ...

Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis—the detection ...

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis – the ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Older men with prostate cancer who receive federal housing assistance at the time they are first diagnosed have better ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

Older men with prostate cancer who receive federal housing assistance at the time they are first diagnosed have better ...

Radium-223 retains a role in osteoblastic bone-only disease, while PSMA PET has become indispensable across staging, ...